Observational studyEuropean urology2019

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.

Catherine H Marshall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.